Prominent Specialty Generics Market Trend for 2025: New Approval To Address The Critical Need For Medication

What industry-specific factors are fueling the growth of the specialty generics market?
The rising incidence of chronic diseases is set to stimulate demand in the specialty generic market. Defined as long-lasting illnesses that are frequently non-curable, chronic diseases can sometimes be managed or cured. The shift in lifestyles, dietary habits, and lack of weight maintenance are key contributors to these ailments, with some long-term chronic conditions even increasing the risk of cancer. As exposure to these diseases increases, there is a growing necessity for specialty generic treatments to manage complex chronic diseases. For instance, the World Health Organization, a Switzerland-based UN agency, reported in September 2022 that there were 41 million deaths corresponding to 74% of deaths worldwide due to non-communicable diseases (NCDs) or chronic diseases. Out of these, cardiovascular diseases claimed 17.9 million lives, cancer caused 9.3 million deaths, chronic respiratory diseases resulted in 4.1 million fatalities, and diabetes accounted for 2.0 million. Hence, the rising prevalence of chronic diseases is propelling the growth of the specialty generic market.

Get Your Specialty Generics Market Report Here:
https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

What Is the projected market size and growth rate for the specialty generics market?
The size of the specialty generics market has seen rapid expansion in the past few years. It is predicted to balloon from $95.87 billion in 2024 to $108.11 billion in 2025, reflecting a compound annual growth rate (CAGR) of 12.8%. Factors contributing to growth during the historical period include the expiration of patents for brand-name medications, an increasing need for cost-friendly substitutes, regulatory endorsement for generic drug approvals, mounting pressures on healthcare costs, the growth of chronic illnesses, and the increasing number of older adults.

Anticipations are high for a significant expansion in the specialty generics market in the coming years, with projections estimating a growth to $189.72 billion in 2029, at an annual compound growth rate (CAGR) of 15.1%. This growth for the forecast period is linked to various factors such as the expansion of biosimilars market, focus on the development of complex generic drugs, increasing attention towards specialty generic injectables, adoption of 3D printing in the manufacture of specialty generics, and the growth of this market in emerging economies. The forecast period also expects to see trends like personalized and targeted specialty generics, strategic alliances and collaborations for generic drug development, emphasis on creating abuse-deterrent formulations, integration of digital healthcare technologies in specialty generics, and regulatory initiatives pushing for speedy approval of complex generics.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7781&type=smp

What new trends are reshaping the specialty generics market and its opportunities?
Leading businesses in the specialty generic market are gaining approval for drugs like Lisdexamfetamine Dimesylate, addressing a vital necessity for medication. In the context of specialty generics, approval signifies the regulatory permission given to pharmaceutical items that are bioequivalent and therapeutically similar to branded specialty drugs. These are generally employed in treating complicated or rare health conditions once their patent safeguards have lapsed. For example, in August 2023, Mallinckrodt plc, a specialty pharmaceutical firm based in Ireland, obtained FDA endorsement for its SpecGx LLC Specialty Generics segment's Lisdexamfetamine Dimesylate Capsules to treat Attention-Deficit/Hyperactivity Disorder (ADHD). Lisdexamfetamine Dimesylate is a federally-controlled substance (CII) and a kind of specialty generic utilized to address ADHD and other conditions.

What major market segments define the scope and growth of the specialty generics market?
The specialty generics market covered in this report is segmented -

1) By Route Of Administration: Injectables, Oral, Other Route Of Administration
2) By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication
3) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Hospital Pharmaciesx

Subsegments:
1) By Injectables: Intravenous (IV) Injectables, Intramuscular (IM) Injectables, Subcutaneous (SC) Injectables
2) By Oral: Tablets, Capsules, Liquid Formulations
3) By Other Route Of Administration: Topical, Transdermal, Inhalation

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7781

Which region dominates the specialty generics market?
North America was the largest region in the specialty generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specialty generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Which key market leaders are driving the specialty generics industry growth?
Major companies operating in the specialty generics market include Teva Pharmaceutical Industries Ltd., Endo International plc, Akorn Operating Company LLC, Mallinckrodt Pharmaceuticals, Dr. Reddy's Laboratories Ltd., Fresenius Kabi Brasil Ltda, STADA Arzneimittel AG, Cipla Limited, Lupin Ltd, Aurobindo Pharma Limited, Aspen Pharmacare Holdings Limited, Pfizer Inc., Accord Healthcare Limited, Amneal Pharmaceuticals Inc., Sandoz International GmbH, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Impax Laboratories Inc., Par Pharmaceutical Companies Inc., Alvogen, Alkem Laboratories Ltd., Wockhardt Ltd., Strides Pharma Science Limited, Indoco Remedies Ltd., Unichem Laboratories Ltd., Alembic Pharmaceuticals Ltd., Jubilant Life Sciences Ltd.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=7781&type=smp

What Is Covered In The Specialty Generics Global Market Report?

•Market Size Forecast: Examine the specialty generics market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the specialty generics market for a structured understanding.
•Key Players Overview: Analyze major players in the specialty generics market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the specialty generics market.
•Segment Contributions: Evaluate how different segments drive overall growth in the specialty generics market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the specialty generics market.
•Industry Challenges: Identify potential risks and obstacles affecting the specialty generics market.
•Competitive Landscape: Review strategic developments in the specialty generics market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.